文献速递心境障碍

重性抑郁障碍的功能性与结构性皮层缺陷模式生物标志物

Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该病例对照研究利用UKBB、ENIGMA、ACP和ACI四个数据集,检验皮层区域均匀性(ReHo)模式能否作为重性抑郁障碍(MDD)更敏感的生物标志物。MDD患者皮层ReHo降低而皮层厚度无显著差异,ReHo效应模式与区域脑血流量(RCBF)模式显著相关。基于ReHo的区域脆弱性指数(RVI)效应量数值上强于结构RVI,且与抑郁症状严重度相关。

要点

  • MDD患者皮层ReHo在扣带回、颞上叶、额叶等区域降低,皮层厚度无显著差异。
  • ReHo的MDD效应量区域模式与两个独立数据集的RCBF模式显著相关(r=0.52和r=0.46;P<10-4)。
  • ReHo和RCBF功能RVI的效应量(Cohen d=0.33-0.90)数值上强于结构RVI(Cohen d=0.09-0.20)。

核心结论

  • 该病例对照研究结果提示,ReHo的MDD缺陷模式反映皮层低灌注且在MDD中具有区域特异性。
  • 基于ReHo的RVI可能作为MDD的敏感功能生物标志物。

研究设计与样本

  • 病例对照研究,纳入4个数据集:UKBB(N=4810,复发MDD 2220例,对照2590例;平均[SD]年龄63.0[7.5]岁;女性1121例[50%])、ENIGMA(N=10115,MDD 2148例,健康对照7957例;平均[SD]年龄39.9[10.0]岁;女性5927例[59%])、ACP(N=204,终生MDD诊断68例,对照136例;平均[SD]年龄41.0[14.5]岁;女性104例[51%])和ACI(N=372,复发MDD 296例,对照76例;平均[SD]年龄45.3[17.2]岁;女性189例[51%])。
  • UKBB参与者有ReHo和结构测量,ENIGMA参与者用于测量MDD结构皮层缺陷模式,ACP有ReHo、结构和RCBF数据,ACI样本的RCBF数据用单光子发射计算机断层扫描测量。
  • 数据分析时间为2021年8月至2024年9月。

主要发现

  • MDD参与者皮层ReHo在扣带回、颞上叶、额叶和其他几个区域较低,皮层厚度无显著差异。
  • ReHo的MDD效应量区域模式与两个独立数据集获得的RCBF模式显著相关(Pearson r=0.52和Pearson r=0.46;P<10-4)。
  • ReHo和RCBF功能RVI显示数值上更强的效应量(Cohen d=0.33-0.90),相比结构RVI(Cohen d=0.09-0.20)。
  • 在MDD个体中,基于ReHo的RVI-MDD值升高与各队列中更高的抑郁症状严重度相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Major depressive disorder (MDD) is a severe mental illness characterized more by functional rather than structural brain abnormalities. The pattern of regional homogeneity (ReHo) deficits in MDD may relate to underlying regional hypoperfusion. Capturing this functional deficit pattern provides a brain pattern-based biomarker for MDD that is linked to the underlying pathophysiology. OBJECTIVE: To examine whether cortical ReHo patterns provide a replicable biomarker for MDD that is more sensitive than reduced cortical thickness and evaluate whether the ReHo MDD deficit pattern reflects regional cerebral blood flow (RCBF) deficit patterns in MDD and whether a regional vulnerability index (RVI) thus constructed may provide a concise brain pattern-based biomarker for MDD. DESIGN, SETTINGS, AND PARTICIPANTS: The UK Biobank (UKBB) participants had ReHo and structural measurements. Participants from the Enhancing Neuroimaging Genetics Through Meta-Analysis (ENIGMA) Consortium were included for measuring the MDD structural cortical deficit pattern. The UKBB ReHo and ENIGMA cortical thickness effect sizes for MDD were used to test the deficit patterns in the Amish Connectome Project (ACP) with ReHo, structural, and RCBF data. Finally, the Ament Clinic Inc (ACI) sample had RCBF data measured using single-photon emission computed tomography. Data were analyzed from August 2021 to September 2024. EXPOSURES: ReHo and structural measurements. RESULTS: Included in this analysis were 4 datasets: (1) UKBB (N = 4810 participants; 2220 with recurrent MDD and 2590 controls; mean [SD] age, 63.0 [7.5] years; 1121 female [50%]), (2) ENIGMA (N = 10 115 participants; 2148 with MDD and 7957 healthy controls; mean [SD] age, 39.9 [10.0] years; 5927 female [59%]), (3) ACP (N = 204 participants; 68 with a lifetime diagnosis of MDD and 136 controls; mean [SD] age, 41.0 [14.5] years; 104 female [51%]), and (4) ACI (N = 372 participants; 296 with recurrent MDD and 76 controls; mean [SD] age, 45.3 [17.2] years; 189 female [51%]). MDD participants had lower cortical ReHo in the cingulum, superior temporal lobe, frontal lobe, and several other areas, with no significant differences in cortical thickness. The regional pattern of ReHo MDD effect sizes was significantly correlated with that of RCBF obtained from 2 independent datasets (Pearson r = 0.52 and Pearson r = 0.46; P < 10-4). ReHo and RCBF functional RVIs showed numerically stronger effect sizes (Cohen d = 0.33-0.90) compared with structural RVIs (Cohen d = 0.09-0.20). Elevated ReHo-based RVI-MDD values in individuals with MDD were associated with higher depression symptom severity across cohorts. CONCLUSIONS AND RELEVANCE: Results of this case-control study suggest that the ReHo MDD deficit pattern reflected cortical hypoperfusion and was regionally specific in MDD. ReHo-based RVI may serve as a sensitive functional biomarker for MDD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kochunov P, Adhikari BM, Keator D, et al. Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder. JAMA Psychiatry. 2025. PMID: 40172866. doi:10.1001/jamapsychiatry.2025.0192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。